Category health

Abhishek Aggrawal, CEO, Birla Fertility & IVF

“India’s health system has made significant progress in prevention, diagnostics, and treatment. Fertility care now needs to be formally integrated into this framework as part of comprehensive family health planning.

Budget 2026 has an opportunity to enable earlier and more efficient fertility care through practical measures. Integrating fertility screening into preventive health programmes and extending insurance coverage to diagnostics and early stage interventions would allow people to seek care sooner, when treatment is more effective and costs are better controlled.

Access must be matched with quality. National standards for fertility laboratories, structured training for embryologists, and consistent clinical protocols are essential to delivering safe and reliable outcomes across the country.

These are targeted investments with long term returns. Strong fertility care infrastructure supports family formation, demographic stability, and a more resilient healthcare system, making it a logical inclusion in India’s health and economic planning.”

Chennai, Jan 29: Kauvery Hospital, Vadapalani, successfully diagnosed a rare and elusive pancreatic tumour known as an insulinoma in a 60-year-old woman, causing persistently low blood sugar and frequent loss of consciousness.

The hospital followed a stepwise diagnostic approach. Initial imaging studies, including a contrast CT scan and a specialised PET scan, did not clearly identify the cause. The breakthrough came with specialised blood tests measuring insulin and C-peptide levels, followed by a targeted endoscopic ultrasound (EUS), which ultimately helped locate the tumour.

The tumour’s small size and challenging location added a further layer of complexity. Measuring just 1.3 cm, it was located at the neck of the pancreas and surrounded by vital structures. The surgical team therefore opted for a robotic-assisted approach, using robotic intraoperative ultrasound (RIOUS) to accurately localise and safely remove the tumour.

The surgery was successful, with the patient’s blood sugar levels started normalising immediately after the procedure. She made a rapid recovery and was able to return to normal activity the very next day.

The diagnostic team was led by Dr. P. Basumani, Senior Consultant and Director, Kauvery Institute of Digestive Sciences, Kauvery Hospital, Vadapalani, while the robotic procedure was performed by Dr. Swaminathan Sambandam, Senior Consultant and Lead, Multi-Organ Transplant (Liver, Kidney, Pancreas and Small Intestine), Kauvery Hospital, Vadapalani.

In his comments Dr.  Basumani said,

“Insulinomas are extremely difficult to locate, especially when they are very small. In this case, even advanced imaging did not give us clear answers. Specialised blood tests combined with focused Endoscopic Ultrasound Evaluation helped us precisely identify the tumour.”

Dr. Swaminathan Sambandam said,

“This was a technically demanding surgery. Tumours of this size and location are extremely challenging to operate on through conventional methods. Robotic surgery, supported by intraoperative ultrasound, gave us unmatched precision and control. Very few hospitals in the country have access to this level of technology.”

In his comments, Dr Aravindan Selvaraj, Co-founder and Executive Director, Kauvery Group of Hospitals, said,

“This case reflects the strength of clinical teamwork, perseverance in diagnosis, and the role of advanced technology in handling rare pancreatic and endocrine tumours. It reinforces Kauvery Hospital’s commitment to clinical excellence, advanced diagnostics and state-of-the-art robotic surgery”.

Bangalore, Jan 29: Cervical cancer is often silent, undetected, and devastating. But what if the story could be changed? What if prevention was within reach—right now?

Cervical cancer: A preventable crisis

Cervical cancer is the second most common cancer among women in India, responsible for nearly 20% of all female cancer cases. The good news is that 90% of these cases are preventable with timely vaccination and screening. Yet, fewer than 2% of women between 30–49 have ever been screened. This isn’t due to a lack of concern, but because many women lack the access, awareness, and support to act early. The solution is simple, taking an HPV (Human Papillomavirus vaccine) in advance as a preventive measure.

Prevention Starts with Early Action

What if families could act before cervical cancer even has a chance? Tata AIA Health Buddy empowers families to take control of their health. With easy access to HPV vaccination as part of Health Buddy benefits, our consumers can ensure they are protected from cervical cancer, that too at discounted rates. Tata AIA removes the hassle of external appointments and complicated procedures, enabling families to act when it matters most.

Sujeet Kothare, Chief of Products, Marketing, Corporate Communications & Business Mid Office, Tata AIA Life Insurance said,

 “Cervical cancer remains a significant threat to women’s health in India, but prevention is within our control. Taking proactive steps, such as the HPV vaccination, can help protect future generations. At Tata AIA, we are committed to empowering women with the tools they need to live healthy lives. Through our Tata AIA Health Buddy benefits, we offer exclusive discounts on HPV vaccinations, reinforcing our dedication to the well-being of the communities we serve. Together, we can make a lasting impact in the fight against cervical cancer.”

More than just Vaccination: Comprehensive support at every step

Cervical cancer prevention is just the beginning. Tata AIA Health Buddy is designed to support families throughout their health journeys:

• Doctor Consultations: Easy access to expert advice when needed.
• Health Check-ups: Regular monitoring to stay ahead of health needs.
• Medical Second Opinions & Case Management: Dedicated support for families during critical health challenges.
• Extra Savings: Discounts on prescribed medicines and lab tests.

These services aren’t just about convenience—they’re about giving families the tools to make informed decisions and the peace of mind that comes with knowing they are supported at every step of the way.

Real benefits for the Whole Family

Health decisions affect the entire family. Whether it’s a mother, wife, sister, or daughter, caring for loved ones is a shared responsibility. With Tata AIA Health Buddy, the whole family has access to crucial health services, empowering them to stay healthy. And it’s not just policyholders who benefit; Tata AIA extends these services to nominees and family members as well.

Shifting the Focus: Life Insurance that cares about Health

What if life insurance was about more than just financial protection? What if it was about proactive care, early action, and long-term health management? Tata AIA is shifting the paradigm. With Tata AIA Health Buddy, the company is not only protecting families’ financial futures—it’s helping them stay healthy, stay informed, and take charge of their well-being every step of the way.

New Delhi, Jan 28: TATA Starbucks today announced an enhancement to beverage customisation across its stores in India, empowering customers to enjoy their favourite flavoured hot or iced beverages with greater personalisation to choose their preferred level of sweetness with zero-sugar flavours such as Vanilla, Hazelnut and Caramel now also available with zero added sugar, customers can select from options including No Sugar, Less Sweet or Regular, rendering lesser calories beverages, across all Starbucks stores, mobile ordering and delivery platforms.

“India’s coffee culture has evolved significantly over the years, with consumers increasingly seeking more control over how their beverages are crafted,” said Sushant Dash, ceo, Tata Starbucks.

“Sweetness is a key part of that choice, and this enhancement allows customers to decide the level that works for them without altering the flavour profile they are familiar with also with a lower calorie beverage output. It preserves the Starbucks experience consumers expect, while offering greater flexibility at the point of order. Our focus remains on delivering consistency across stores and channels, strengthening our ability to serve a wider range of preferences at scale, while keeping the experience seamless for both customers and partners.”

As health and wellness continue to influence beverage choices, more consumers are paying closer attention to ingredients and calorie intake while still seeking flavour and indulgence. This shift is particularly visible at the start of the year, as resolutions and reset is taking precedence and people reassess everyday choices and routines. With this offering, Starbucks is enabling greater flexibility for customers with options that suit their tastes and daily preferences while upholding the quality, consistency and indulgence that define the signature Starbucks experience.

The customisation options are now available across Starbucks 506 stores in 81 cities, giving customers the ability to select their desired sweetness across beverages.

Delhi, Jan 28: As antimicrobial resistance increasingly complicates infection management, orthopaedic specialists are encountering more cases where standard antibiotic treatment alone is insufficient. In one such case, Dr. Simon Thomas, Director and Head of Robotic Joint Replacement & Reconstruction, Max Hospital, successfully treated an 85-year-old patient with a drug-resistant knee implant infection through a carefully planned, staged surgical approach, demonstrating how complex infections can be managed effectively with timely, evidence-based care.

Implant-related infections present challenges distinct from routine infections. In joint replacements, bacteria can adhere to the implant surface and form a biofilm, reducing the effectiveness of antibiotics if treatment is initiated without identifying the infecting organism. The issue has gained wider attention amid growing concerns around antimicrobial resistance, which has also been highlighted at a national level. In a recent episode of Mann Ki Baat, Prime Minister Narendra Modi cautioned against the misuse and overuse of antibiotics, noting that indiscriminate use can weaken their effectiveness over time. When antibiotics are started without culture confirmation, resistant bacteria may persist, making infections harder to eradicate and recovery more prolonged.

In this case, the patient, Mrs Pushpa, had undergone bilateral knee replacement surgery in March 2022 and remained active for several years. In early 2025, she developed persistent pain and swelling in both knees. Further evaluation, including joint fluid analysis and laboratory investigations, identified Achromobacter xylosoxidans, a rare organism known for resistance to commonly used antibiotics. Implant-related infections require specialised management, particularly in elderly patients, where treatment decisions must carefully balance infection control with overall safety.

Explaining the clinical approach, Dr. Simon Thomas, Director and Head of Robotic Joint Replacement & Reconstruction, Max Hospital, said, “Implant-related infections are especially challenging today because antimicrobial resistance limits treatment options. In these cases, starting antibiotics without identifying the organism can allow resistant bacteria to persist. A step-by-step approach, based on accurate diagnosis, targeted antibiotics, and timely surgery, is essential to control the infection while protecting long-term joint function.”

Adding to this, Dr. Divesh Gulati, Associate Director Robotic Joint Replacements & Orthopaedics, Max Hospital, Shalimar Bagh, said,

“Cases like this underline the importance of restraint and precision in infection management. When antimicrobial resistance is involved, every decision—from investigation to intervention—must be deliberate. A structured, staged strategy not only improves outcomes but also avoids unnecessary procedures, which is especially critical in elderly patients.”

Mrs Pushpa added,

“At my age, the infection was worrying, and I was unsure how well I would recover. The treatment was explained clearly and carried out step by step, which helped reassure me. I am now recovering steadily and able to move better.”

In May 2025, the infected implant from the patient’s left knee was removed, and the joint was thoroughly cleaned. This was followed by high-dose, culture-specific antibiotic therapy. After infection parameters stabilised, a second-stage revision knee replacement was performed using a high-stability implant, with intra-operative checks confirming infection clearance before implantation. During the same hospital stay, the patient’s right knee, which showed raised inflammatory markers, was evaluated cautiously through joint aspiration and laboratory testing, helping rule out active infection and avoid unnecessary surgery. Despite her age, the patient tolerated the procedures well and is currently undergoing supervised rehabilitation to improve mobility and daily function.

The case highlights the growing clinical impact of antimicrobial resistance and the need for early diagnosis, targeted treatment, and appropriate surgical intervention. It demonstrates that with specialised care and careful planning, even complex, drug-resistant implant infections can be managed successfully in elderly patient

Navi Mumbai, Jan 23: A 41-year-old man from Mauritius, who had been living with debilitating hip pain for over 11 years due to advanced Avascular Necrosis (AVN), has successfully avoided hip replacement surgery after undergoing cell-based regenerative therapy at StemRx Hospital & Research Centre, Navi Mumbai. Treated under the care of Dr. Pradeep Mahajan, Regenerative Medicine Researcher and Founder of StemRx, the patient has experienced significant pain relief, improved mobility, and a renewed quality of life.

Mr. Kavraj Singh Bohani had been suffering from persistent pain, stiffness, and severely restricted movement for more than a decade. Over the last three to four years, his condition worsened considerably, affecting his ability to walk, sleep, work, and perform everyday activities. Multiple medical consultations in Mauritius recommended hip replacement surgery as the only viable option. Long-term use of pain medication offered only temporary relief and began impacting his mental and emotional well-being.

In search of a non-surgical, root-cause-focused solution, Mr. Bohani learned about StemRx through the Medi Check Clinic in Mauritius and decided to travel to India for treatment.

At StemRx Hospital, a comprehensive evaluation confirmed advanced AVN of the hip, a condition caused by reduced blood supply to the bone, leading to bone damage and joint degeneration. Based on the assessment, the medical team designed a personalised regenerative medicine protocol aimed at restoring blood flow, reducing inflammation, and stimulating natural bone healing.

Even before the primary therapy commenced, the patient showed improvement through supportive care and physiotherapy. He subsequently underwent stem cell-based regenerative therapy, supported by a multidisciplinary treatment approach that included targeted cell therapy, physiotherapy, quantum energy medicine, Hyperbaric Oxygen Therapy (HBOT), and EBOO (Extracorporeal Blood Oxygenation and Ozonation). The integrated strategy focused on slowing or halting disease progression, relieving pain, improving joint function, and avoiding joint replacement surgery.

Commenting on the case, Dr. Pradeep Mahajan, Regenerative Medicine Researcher & Founder, StemRx Hospital & Research Centre, said,

“Avascular necrosis develops when the blood supply to the bone is compromised, leading to progressive damage and severe pain. In many cases, joint replacement is advised as the final option. Our approach focuses on addressing the disease at the cellular level—by improving blood flow, reducing inflammation, and stimulating bone regeneration. In Mr. Bohani’s case, a customised stem cell therapy protocol helped support recovery of the hip joint and significantly improve his quality of life.”

He added,

“What stood out in this case was the patient’s determination and trust in the treatment process. With consistent therapy and rehabilitation, we observed meaningful improvements in pain levels, mobility, and overall function. This case highlights how regenerative medicine can offer hope to patients who believe surgery is their only option.”

Sharing his experience, Mr. Kavraj Singh Bohani said,

“For years, pain controlled every part of my life. I couldn’t work properly, sleep peacefully, or even step out without discomfort. Doctors told me surgery was the only way forward. Coming to StemRx changed everything. Today, I am almost pain-free and no longer dependent on medicines. I finally feel hopeful again.”

He further added,

“Dr. Mahajan gave me confidence from day one. His calm approach and clear explanations made me feel safe throughout the treatment. Before opting for a hip replacement, I would strongly encourage anyone suffering from AVN to explore regenerative therapy. It truly gave me my life back.”

This case underscores the potential of cell-based regenerative medicine in offering effective, non-surgical treatment options for chronic and debilitating conditions such as Avascular Necrosis—helping patients restore mobility, dignity, and long-term quality of life.

Mumbai, Jan 22 : In a powerful demonstration of student-led change, Salaam Bombay Foundation’s Preventive Health Education Programme marked the 20th version of its flagship forum Bal Parishad, that enables adolescents from resource-challenged communities directly engage with policymakers and authorities and help create change for the well-being of their communities.

Led entirely by students known as Health Monitors, the Bal Parishad brought together over 200 students from government and government-aided schools and was attended by senior policymakers and administrators. Dignitaries present included Hon. Minister Dr. Pankaj Bhoyar, School Education, Maharashtra; Shri Ranjit Singh Deol (IAS), Principal Secretary, School Education and Sports Department; Hon. Mr. Vijayakant Sagar, Deputy Commissioner of Police;  Mrs. Sujata Khare, Education Officer, MCGM; and Dr. Umesh Shirodkar, Joint Director, Public Health Department, Maharashtra.

Trained under Salaam Bombay Foundation’s Preventive Health Education Programme, the Health Monitors used the platform to highlight real-world challenges within their communities, including tobacco use, hygiene and nutritional gaps. Through direct interactions with policymakers, students presented practical, evidence-based recommendations and shared community initiatives such as poster campaigns, door-to-door outreach and collaboration with local leaders. The Bal Parishad also recognised young changemakers whose efforts demonstrated how awareness, confidence and student-led action can drive meaningful and lasting change.

 Minister Dr. Pankaj Bhoyar  School Education, Maharashtra said,

 “Today, we witnessed how a committed social organisation can drive meaningful change in society. The confidence with which the students presented, and the joy on their faces reflect the true impact of such initiatives. This, to me, is real success. The work being undertaken by Salaam Bombay Foundation addresses a critical need of our times, and the government and the administration will continue to stand firmly in support of such efforts.”

Shri. Ranjit Singh Deol Principal Secretary, School Education and Sports Department said,

 “The Bal Parishad is truly a unique programme. We are seeing children step forward as agents of social awareness. Through the student success stories, we can see that when a child is determined, they can mobilise their community: whether it is addressing waste management or other public health concerns and bring about real, measurable change. I extend my best wishes to all the students for the meaningful impact they can create as Health Monitors.”

Speaking on the occasion, Tshering D. Bhutia, Chief Innovation Officer and Senior Vice President, Projects Salaam Bombay Foundation said,

“What we witnessed today was children speaking truth from lived realities. Bal Parishad reaffirmed that when we listen to young voices, we help break the cycle of fear and ignorance, and nurture confident voices and conscious choices.”

The Bal Parishad was conceptualised under Salaam Bombay Foundation’s Preventive Health Education Programme which began in 2002 as an initiative to steer students away from tobacco and break cycles of addiction and poor health. Since then, the programme has branched out to include every aspect of its students’ health: resistance to tobacco use, awareness about nutrition, looking out for their mental well-being with an overall focus on life skills. Through the Bal Parishad, the Preventive Health Education Programme has empowered thousands of students to work with relevant policymakers and stakeholders to bring about positive change in their communities. It goes beyond awareness of healthy practices, to opening up a portal to leadership and long-term community impact.

As Salaam Bombay Foundation celebrated two decades of Bal Parishad, the message remains clear when young people are equipped with knowledge, confidence and a platform, they don’t just speak up, they help break cycles and reshape the future of their communities.

New Delhi,  Jan 22: Manipal Hospital, Broadway, a unit of one of the leading healthcare providers of Eastern India  Manipal Hospitals Group, has successfully performed its first-ever stem cell therapy for an advanced case of Peripheral Arterial Disease  on 62-year-old-male patient, Asish Mukherjee  retired government employee from Kolkata under the expertise of Dr. Jayanta Das,Consultant- Vascular and Endovascular Surgery, Manipal Hospital, Broadway and Dr. Krishnendu Mukherjee, Consultant  Vascular and Endovascular Surgery, Manipal Hospital, Broadway.

The patient was a chronic smoker, had been diagnosed with PAD nearly a year ago and was initially advised angioplasty with possible stenting. Peripheral Arterial Disease (PAD) is a condition in which the blood vessels in the legs become narrowed or blocked, reducing blood flow. This can cause leg pain, non-healing wounds, and in severe cases, infection or amputation. Smoking, diabetes, and high cholesterol are common causes. However, due to delayed follow-up and disease progression, he later presented with severe critical limb ischemia and an active non-healing ulcer. Advanced angiography revealed that conventional surgical options were no longer feasible due to the absence visible arterial lumen  With amputation the only option left, the team led by Dr. Jayanta Das proposed stem cell therapy, a treatment where special cells are used to help repair damaged tissues and improve blood flow, especially when other treatments are not possible.

The patient was admitted to the hospital on the same day the procedure was conducted and he was discharged on the following day. Within 24 hours, the patient experienced complete relief from pain through a remarkable early outcome. The healing response of the ulcer will be assessed over the next six weeks.

Speaking about the case, Dr. Jayanta Das said,

“In advanced Peripheral Arterial Disease, when angioplasty or bypass surgery is no longer possible due to complete blockage of blood vessels, stem cell therapy offers a promising limb-saving option. In this case, the patient had no viable surgical alternative and was at high risk of amputation. The therapy resulted in significant relief from severe rest pain within 24 hours, highlighting the potential of regenerative medicine to improve blood flow and quality of life in patients with critical limb ischemia.”

Adding to this, Dr. Krishnendu Mukherjee said,

“Critical limb ischemia caused by severe arterial blockage leaves very limited treatment options, and in many cases, patients are pushed towards amputation. In this case, stem cell therapy was carefully planned and executed after thorough evaluation, as no conventional surgical or endovascular intervention was feasible. The early clinical response, particularly the rapid relief from rest pain, is encouraging and highlights the role of advanced regenerative procedures in managing complex vascular cases.”

Sharing his relief, Asish Mukherjee said,

“When I was told that surgery was no longer possible and amputation might be needed, I felt helpless. Stem cell therapy gave me a new option and new hope. Within a day, my pain reduced significantly, and I am grateful to the team at Manipal Hospital Broadway for this treatment.”

Panchkula, Jan 21: Reinforcing the critical importance of emergency medical services in saving lives, Paras Health Panchkula organised ‘Ambulance Rally 2026’ at its Panchkula facility on Sunday to recognise the contribution of ambulance staff, emergency responders, and frontline healthcare professionals. The rally acknowledged their role as the first line of response during medical emergencies, remaining on call round the clock to ensure timely pre-hospital care.

The rally was organised in the esteemed presence of Ms Seema Chaudhary, Former Mayor of Panchkula, who addressed the gathering and underscored the importance of coordinated emergency response and effective traffic management in saving lives during critical situations.

Held under the theme “Heroes of Healthcare Emergency Always on Call. Always on Wheels.”, the initiative sought to raise public awareness about the importance of timely emergency response and the role of pre-hospital care in improving patient outcomes. The rally also underscored how swift coordination between ambulance teams and hospitals can often make the difference between life and loss.

The rally commenced from Paras Hospital, Panchkula, and followed a designated route from the hospital to Bella Vita Restaurant and back, symbolising the continuous readiness of emergency medical services. The movement of ambulances across the city served as a visual reminder of the critical role emergency responders play in bridging the gap between medical emergencies and timely, lifesaving treatment.

Speaking on the occasion, Dr. Pankaj Mittal, Facility Director, Paras Health Panchkula, said, 

“Emergency outcomes depend heavily on what happens before a patient reaches the hospital. Ambulance teams are responsible for early assessment, stabilisation, and timely handover, which significantly influences clinical outcomes. This rally was a way to formally recognise their role in the emergency care continuum and to reinforce the importance of faster, better-coordinated pre-hospital response systems.”

The event witnessed active participation from Paras Health’s emergency response teams and healthcare staff, reflecting the hospital’s continued emphasis on preparedness, rapid response, and compassionate care. The rally also served as a moment of recognition for the discipline, resilience, and commitment displayed by ambulance personnel who work under high-pressure situations every day.

Paras Health Panchkula continues to strengthen its emergency care services through investments in advanced medical infrastructure and highly trained medical teams, ensuring timely, coordinated, and quality care for patients in critical conditions.

10.4 kgs Abdominal Tumour measuring 50 cms Successfully Removed from 80-year-old Woman at Fortis Escorts Okhla

New Delhi,  Jan 20: Doctors at Fortis Escorts Okhla, New Delhi, have accomplished a remarkable surgical feat: a multidisciplinary team led by Dr Archit Pandit, Director – Surgical Oncology, Fortis Escorts Okhla alongside Dr Vineet Goel ,Consultant – Surgical Oncology, Fortis Escorts Okhla, Dr Kushal Bairoliya, Consultant – Surgical Oncology & GI Surgery, Fortis Escorts Okhla and Dr Manju, Senior Consultant, Anaesthesia & Critical Care, Fortis Escorts Okhla, successfully removed an exceptionally large abdominal tumour from an 80-year-old woman. The tumour – a diagnosis of Liposarcoma, is a rare cancer originating in fatty tissues –  had grown aggressively, invading deeply into the patient’s abdomen. It compressed critical structures including the kidneys, colon, urinary bladder and uterus. Despite the patient’s advanced age, multiple co-morbidities and the extreme complexity of the surgery, the team carried out the resection successfully. The patient was discharged in stable condition just 12 days post the surgery, an outcome that highlights both the surgical team’s skill and the strength of the hospital’s multidisciplinary cancer-care programme.

The elderly lady was presented to Fortis Escorts Okhla, with significant abdominal distension – her abdomen had swollen so significantly that it resembled a pregnant pouch. Despite having sustained bloating and abdominal discomfort for over two years, she had been treated at other hospitals merely with anti-gas medications, and no advanced diagnostic imaging had been performed. On evaluation at Fortis Escorts Okhla, imaging revealed a massive tumour in her abdominal cavity. The mass was diagnosed as a Liposarcoma –  a rare malignant tumour of fatty tissue. The surgery required meticulous planning and cross‐specialty coordination. During the surgery, the doctors painstakingly separated the tumour from adjacent organs, preserving the functional integrity of compressed kidneys and intestines, despite the extreme size and complexity of the mass. While the largest liposarcoma reported in literature weighed ~45 kgs, tumors above 10 kgs are exceedingly rare, with very few such resections published in India and globally.

Giving details of the case, Dr. Archit Pandit, Director – Surgical Oncology, Fortis Escorts, Okhla Road, said,

“Operating on a patient in such a fragile condition was extremely challenging. The true complexity lies not only in removing the tumour but in ensuring functional recovery with dependable reconstruction. Given the tumour’s size, its proximity to vital organs and the risk of severe intra-operative bleeding, this surgery required extensive planning and precise execution. Such cases test the limits of surgical oncology and are only possible through a coordinated, multi-disciplinary effort. Our priority was not just to remove the tumor but also to preserve the patient’s quality of life, which we were able to achieve successfully.”

Dr Vikram Aggarwal, Facility Director, Fortis Escorts Okhla Road, New Delhi said,

“Globally, liposarcomas of this magnitude are extremely rare, with only a handful of cases exceeding 10 kgs documented in the medical literature. Fortis Escorts’ successful resection of a 10.4 kg tumour underscores the hospital’s expertise, advanced infrastructure, and commitment to delivering world-class oncological care for even the most complex cases.